Specifically, AG activates tumor‐associated mast cells (TAMCs), reprogrammes myofibroblastic cancer‐associated fibroblasts (myCAFs) into inflammatory CAFs (iCAFs), and enhances suppressive crosstalk between TAMCs, iCAFs, and T cells via the macrophage migration inhibitory factor (MIF) axis. The gene discussed is MIF; the disease is cancer.